8
Participants
Start Date
June 30, 2014
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Naltrexone and 2-butanol
50mg of Naltrexone and 40 or 80 mg of 2-butanol (depending on Stability Formulation in the first part of the study)
2-butanol which is encapsulated (size 3 capsule) plus 50 mg of naltrexone (HCl form)
a capsule-in-capsule (CIC) design, will be prepared in the pharmacy by incorporating 40 or 80 mg (determined from the first part of the study) of 2-butanol which is encapsulated (size 3 capsule) plus 50 mg of naltrexone (HCl form) in a size 0 double blind hard gel capsule.
University of Florida, Gainesville
National Institute on Drug Abuse (NIDA)
NIH
Xhale Assurance
INDUSTRY